Abstract
Next generation sequencing in tissue is limited by sample availability and turnaround time. Here, we present the first results of the CLIMB360 study, where we performed prospective and real-time sequencing of ctDNA across multiple metastatic cancer types.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have